MedPath

Magnesium sulfate

Generic Name
Magnesium sulfate
Brand Names
Concept Ob, Suflave, Suprep Bowel Prep Kit, Tis-U-sol
Drug Type
Small Molecule
Chemical Formula
MgO4S
CAS Number
7487-88-9
Unique Ingredient Identifier
ML30MJ2U7I
Background

A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)

Indication

Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.

Associated Conditions
Constipation, Convulsions, Hypomagnesemia, Torsades de Pointes, Barium poisoning, Severe Exacerbation of asthma
Associated Therapies
Bowel preparation therapy, Soaking aid for minor sprains and bruises

Efficacy of Intraoperative Magnesium Sulphate vs Dexmedetomidine on Emergence Agitation in Pediatric Patients

Not Applicable
Completed
Conditions
Magnesium Sulphate
Dexmedetomidine
Emergence Agitation
Pediatric Patients
Interventions
First Posted Date
2025-05-18
Last Posted Date
2025-05-18
Lead Sponsor
Ain Shams University
Target Recruit Count
60
Registration Number
NCT06977425
Locations
🇪🇬

Ain shams university, Cairo, Egypt

Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia

Phase 3
Not yet recruiting
Conditions
Cough
Interventions
First Posted Date
2025-05-18
Last Posted Date
2025-05-18
Lead Sponsor
Al-Azhar University
Target Recruit Count
300
Registration Number
NCT06979141

Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke

Phase 1
Not yet recruiting
Conditions
Acute Ischemic Stroke
Interventions
First Posted Date
2025-05-04
Last Posted Date
2025-05-14
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
30
Registration Number
NCT06956521

Magnesium Sulfate in Bronchial Asthma and Acute Bronchiolitis in Children

Phase 3
Not yet recruiting
Conditions
Asthma in Children
Interventions
First Posted Date
2025-05-02
Last Posted Date
2025-05-02
Lead Sponsor
Assiut University
Target Recruit Count
60
Registration Number
NCT06955559

Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery

Phase 1
Active, not recruiting
Conditions
Chronic Rhinosinusitis
Enhanced Recovery After Surgery
Interventions
First Posted Date
2025-04-10
Last Posted Date
2025-04-10
Lead Sponsor
The Second People's Hospital of Huai'an
Target Recruit Count
144
Registration Number
NCT06920576
Locations
🇨🇳

The Affiliated Huaian Hospital of Xuzhou Medical University, Huai'an Second Hospital, Huaian, China

Magnesium and Cramping

Phase 4
Recruiting
Conditions
Uterine Cramps
Postoperative Pain Management
Hysteroscopy
Interventions
First Posted Date
2025-03-25
Last Posted Date
2025-04-03
Lead Sponsor
William Beaumont Hospitals
Target Recruit Count
150
Registration Number
NCT06745388
Locations
🇺🇸

Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States

Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia After Elective Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Dexmedetomidine
Magnesium Sulfate
Adjuvants
Intraperitoneal Bupivacaine
Postoperative Analgesia
Elective Laparoscopic Cholecystectomy
Interventions
First Posted Date
2025-03-17
Last Posted Date
2025-03-17
Lead Sponsor
Tanta University
Target Recruit Count
75
Registration Number
NCT06879288
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation

Phase 3
Not yet recruiting
Conditions
Cerebral Desaturation Events
Spine Surgeries
Interventions
Procedure: spine surgery
Drug: Normal Saline (0.9% NaCl)
First Posted Date
2025-02-27
Last Posted Date
2025-02-27
Lead Sponsor
Tanta University
Target Recruit Count
90
Registration Number
NCT06848595

Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

Phase 2
Not yet recruiting
Conditions
Acute Myeloid Leukemia (AML)
Interventions
Drug: Ca-EDTA
Drug: Multivitamin
First Posted Date
2025-02-06
Last Posted Date
2025-05-18
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
140
Registration Number
NCT06811233
Locations
🇺🇸

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Magnesium Trial in Acute Asthma in Emergency Department

Phase 3
Not yet recruiting
Conditions
Asthma
Interventions
Drug: Normal Saline
First Posted Date
2025-01-21
Last Posted Date
2025-01-21
Lead Sponsor
The Hospital for Sick Children
Target Recruit Count
192
Registration Number
NCT06785272
Locations
🇨🇦

Alberta Children's Hospital, Calgary, Alberta, Canada

🇨🇦

Stollery Children's Hospital, Edmonton, Ontario, Canada

🇨🇦

McMaster Children's Hospital, Hamilton, Ontario, Canada

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath